3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 41.50
+0.75 (1.84%)
Feb 11, 2026, 2:19 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.23 billion as of February 11, 2026. Its market cap has decreased by -31.86% in one year.
Market Cap
3.23B
Enterprise Value
2.55B
Revenue
324.87M
Ranking
n/a
PE Ratio
24.30
Stock Price
41.50
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.23B, an increase of 18.06%. That is a compound annual growth rate of 3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.17B | -15.63% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BRIM Biotechnology | 3.84B |
| Genovate Biotechnology | 3.64B |
| Intech Biopharm | 3.57B |
| Syngen Biotech | 3.47B |
| Shine-On BioMedical | 3.43B |
| Sagittarius Life Science | 3.23B |
| SYN-TECH Chem. & Pharm. | 3.21B |
| Apex Biotechnology | 3.04B |